行情

TXMD

TXMD

TherapeuticsMD
NASDAQ

实时行情|Nasdaq Last Sale

2.060
-0.090
-4.19%
盘后: 2.060 0 0.00% 19:40 02/21 EST
开盘
2.150
昨收
2.150
最高
2.170
最低
2.020
成交量
448.31万
成交额
--
52周最高
6.09
52周最低
1.820
市值
5.59亿
市盈率(TTM)
-2.9838
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测TXMD价格均价为8.75,最高价位16.00,最低价为2.000。

EPS

TXMD 新闻

更多
  • H.C. Wainwright Maintains Buy on TherapeuticsMD, Lowers Price Target to $6
  • Benzinga · 13小时前
  • TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 1天前
  • DPZ, ETFC, VIAC and TXMD among midday movers
  • Seeking Alpha - Article · 1天前
  • TherapeuticsMD +10% premarket on Q4 results
  • seekingalpha · 1天前

所属板块

制药
+0.60%
制药与医学研究
+0.55%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

TXMD 简况

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.
展开

微牛提供TherapeuticsMD Inc(NASDAQ-TXMD)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的TXMD股票新闻,以帮助您做出投资决策。